top of page

PRODUCT COMMERCIALIZATION & TRANSLATION

2023-       NXP900 (a.k.a. eCF506) enter Phase 1 clinical trials (NCT05873686).

2021-       Highly-selective SRC Inhibitor NXP900 (a.k.a. eCF506) licensed to Nuvectis Pharma (USA)

2016-       Highly-selective mTOR Inhibitor eCF309 sold globally by Axon Medchem (Netherlands)

 

2010-14   SAFEctin Transfection Reagent and SAFEctin STEM licensed and produced by Deliverics Ltd (UK) and distributed by Albyn Medical (Spain), CoreSciences (South Korea) and Galen Lab (USA)  

STARTUPS / SPIN-OUT COMPANIES

2015-      THER-IP LTD (SC499733)

2010-16   DELIVERICS LIMITED (SC377672)

Provider of easy-to-use kits for delivering biomolecules into and onto cells

RESEARCH COLLABORATIONS WITH PHARMA

2017-      Merck & Co. through a MRS Award

180px-Logo_Merck_KGaA_2015.svg.png

PATENT APPLICATIONS

PATENT APPLICATIONS

2022  PCT/US2023/017704 Tyrosine kinase inhibitors (Nuvectis Pharma and University of Edinburgh). Priority date: 07/04/2022. Licensed to NUVECTIS PHARMA INC. 

2021   PCT/GB2022/052084 Tyrosine kinase inhibitors (University of Edinburgh). Priority date: 19/08/2021.  Licensed to NUVECTIS PHARMA INC. 

2016   PCT/GB2017/051379 Bioorthogonal prodrugs (University of Edinburgh). Priority date: 29/04/2016. National filing (2019): US, Europe & Japan. 

2015   PCT/GB2016/051057 Compounds (University of Edinburgh). Priority date: 21/05/2015. National filing (2009): US, Europe, Japan, China & Canada. GRANTED in US (US10294227B2), Europe (EP3298015B1), Japan (JP6684831B2), China (CN107849050B) and Canada (CA3021550C).

Licensed to NUVECTIS PHARMA INC. 

2014   PCT/ES2015/070203 Purine Derivatives as DAPK1 Inhibitors (Universidad de Granada & University of Edinburgh). Priority date: 25/03/2014. Granted in Spain (ES2548927B1)

2013   PCT/GB2014/051894 Bioorthogonal Methods and Prodrugs (University of Edinburgh). Priority date: 21/06/2013. National filing (2015): US and Europe. Granted in Europe (EP3010890B1)

2010   PCT/GB2011/000749 Cationic Lipids (University of Edinburgh). Priority date: 18/05/2010. National filing (2011): US (US8759104 B2, granted) and Europe (EP2571527). Licensed to DELIVERICS LTD

2007   PCT/GB2008/003527 Cationic Lipids (University of Edinburgh). Priority date: 19/10/2007. National filing (2009): US, Europe, India, Japan, Australia & Canada. Licensed to DELIVERICS LTD

bottom of page